November 10, 2009 / 4:04 AM / 10 years ago

TABLE-Rohto <4527.OS>-6mth group results

   Nov 10 (Reuters) -
                ROHTO PHARMACEUTICAL CO LTD
                CONSOLIDATED FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
            6 months ended  6 months ended  Full year to    Full year ended
               Sep 30, 2009    Sep 30, 2008    Mar 31, 2010    Mar 31, 2009
               LATEST          YEAR-AGO        COMPANY         YEAR-AGO  
               H1 RESULTS      H1 RESULTS      FORECAST        RESULTS   
 Sales              52.55           51.67          111.00                   
                 (+1.7 pct)                         (+0.4%)              
 Operating           5.26            4.46           11.60                   
                (+17.8 pct)                         (-0.3%)              
 Recurring           5.45            4.52           11.50                   
                (+20.7 pct)                         (+1.3%)              
 Net                 3.10            2.75            7.20                   
                (+12.7 pct)                        (+17.3%)              
 EPS                   Y26.36          Y23.58          Y61.22               
 Diluted   
  EPS                  Y26.25          Y23.38                               
 Annual div                                            Y14.00          Y13.00
  -Q2 div               Y7.00           Y6.00                               
  -Q4 div                               Y7.00           Y7.00               
 NOTE - Rohto Pharmaceutical Co Ltd is a top-ranked eye drops maker.
 For latest earnings estimates made by Toyo Keizai, please
double click on 4527.TK1.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below